Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • pharma-news
    • API should be declared...

    API should be declared strategic sector especially in light of Coronavirus: CII

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2020-03-20T11:00:00+05:30  |  Updated On 20 March 2020 11:00 AM IST
    API should be declared strategic sector especially in light of Coronavirus: CII

    New Delhi: The coronavirus outbreak makes a compelling case for the government to declare active pharmaceutical ingredient (API) as a strategic sector as most inputs are imported, industry body Confederation of Indian Industry (CII) said on Thursday.

    "Firms, for which capacity utilisation is 40 per cent, may be permitted to produce API which is being imported. Approvals for new investments should be fast-tracked," CII said in a statement.

    Blanket environment permission should be provided to manufacture any API on submission of self-certification to comply with pollution load requirement, it added.

    CII also recommended raising API and intermediates produced in the country by creation of large API parks with fiscal benefits for existing API and intermediates plant, supportive regulatory framework and common infrastructure facilitating single-window clearances for API parks.

    For the healthcare sector, CII said the hospitals in larger cities and district hospitals in smaller cities and towns should be identified or designated as 'COVID hospital' for testing and isolation of patients.

    Private sector hospitals can contribute to the required equipment and the manpower, it added.

    The outbreak could also lead to a significant shortage of supply in the medical technology sector as the country heavily imports dependent, CII said.

    "While the real impact on the industry is likely to be visible only after April 2020, the local manufacturer's capacities will need to be bolstered, which would likely become reliable sources amid global shortages," CII said.

    Read also: Coronavirus Outbreak: OPPI assures continuity of supply of medicines

    Medical Dialogues had earlier reported that through a written reply in the Lok Sabha Shri. D.V. Sadananda Gowda, Minister for Chemicals & fertilizers informed the parliament about the import of APIs /drugs and the extent of its dependence on China for the same.

    The Indian Pharmaceutical industry is 3rd largest in the world in terms of volume and 14th largest in terms of value. India exported medicines worth US $14389 mn in Financial Year 2018-19. India also exported Bulk Drug/Drug Intermediates worth the US $ 3911mn in Financial Year 2018-19.

    Read also: India's Dependence On Pharma Imports From China: Minister Informs Parliament

    coronaviruscovid-19apiactive-pharmaceutical-ingredient
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok